ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,011Medicare Part D Prescriptions Filled, Including Refills

Rank: 43 out of 1448

$907K Total Retail Price of All Prescriptions

Rank: 35 out of 1448

546 Patients Receiving at Least One Drug in Part D
60%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 546 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

26% of this provider’s 546 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

1% of this provider’s 7,623 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

35% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$75 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
AMLODIPINE BESYLATE 904 590 1 2
HYDROCODONE-ACETAMINOPHEN 567 388 S3 2 33
FUROSEMIDE 507 337 3 7
SIMVASTATIN 294 191 4 3
METFORMIN HCL 276 164 5 25
CARVEDILOL 267 177 6 1
POTASSIUM CHLORIDE 252 188 7 19
ISOSORBIDE MONONITRATE ER 241 190 8 16
HYDRALAZINE HCL 224 166 9 44
ATORVASTATIN CALCIUM 195 136 10 4
LOSARTAN POTASSIUM 194 149 11 11
OMEPRAZOLE 189 79 12 23
METOPROLOL TARTRATE 179 133 13 9
CRESTOR 174 114 14 17
LISINOPRIL 153 67 15 5
HYDROCHLOROTHIAZIDE 148 102 16 18
IBUPROFEN 145 49 17 85
KLOR-CON 8 139 85 18 70
LEVOTHYROXINE SODIUM 137 109 19 21
TRIAMTERENE-HCTZ 129 86 20 55
GABAPENTIN 126 93 21 51
PANTOPRAZOLE SODIUM 126 80 21 42
FAMOTIDINE 122 84 23 60
AMIODARONE HCL 116 85 24 22
CLONIDINE HCL 105 67 25 45
WARFARIN SODIUM 105 86 25 8
JANUVIA 104 98 27 64
NEXIUM 101 72 28 49
ATENOLOL 100 34 29 12
PROAIR HFA 96 42 30 104
OLANZAPINE 94 0 31 329
LIPITOR 92 56 32 30
METOPROLOL SUCCINATE 89 66 33 6
QUETIAPINE FUMARATE 89 26 33 223
ZOLPIDEM TARTRATE 84 61 35 34
LOSARTAN-HYDROCHLOROTHIAZIDE 83 50 36 38
ACETAMINOPHEN-CODEINE 83 56 S3 36 113
ADVAIR DISKUS 83 49 36 74
PAROXETINE HCL 82 0 39 121
DIGOXIN 81 35 40 13
LANTUS 79 73 41 111
DIOVAN 78 62 42 15
GLYBURIDE 77 33 R 43 89
ACTOS 76 41 44 92
RISPERIDONE 76 38 44 224
EXFORGE 75 71 46 80
PREDNISONE 73 33 47 110
ABILIFY 72 11 48 254
TRIAMCINOLONE ACETONIDE 66 50 49 96
BIDIL 66 40 49 357
NITROSTAT 64 46 51 31
TRIAMTERENE-HYDROCHLOROTHIAZID 63 34 52 156
KLOR-CON 10 62 49 53 102
COMBIVENT 62 22 53 147
GLIMEPIRIDE 62 49 53 66
CLOPIDOGREL 61 42 56 10
SEROQUEL 61 15 56 268
RANEXA 59 46 58 37
AZITHROMYCIN 58 45 59 76
NAMENDA 57 57 60 93
AMLODIPINE BESYLATE-BENAZEPRIL 55 25 61 67
TRAMADOL HCL 55 36 61 56
METOLAZONE 54 48 63 124
LEVOFLOXACIN 54 48 63 131
TAMSULOSIN HCL 53 35 65 46
RAMIPRIL 52 48 66 36
TERAZOSIN HCL 51 26 67 116
ESCITALOPRAM OXALATE 51 14 67 122
ZETIA 50 37 69 28
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 2, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.